NCT05277129 · RECRUITING

The Immune Response to Stroke

This study is tracking how the immune system responds after a stroke, specifically asking whether some patients develop an autoimmune reaction that might explain why their thinking and memory decline afterward. It is an observational study with no drug or treatment involved — researchers are collecting data to understand a mechanism, not testing a therapy. Details on scale and duration are limited.

You may qualify if

  • Stroke \< 72 h
  • Age > 18 years

You're excluded if

  • Brain hemorrhage verified by CT or MRI scan
  • Previous or present immunological disease or other serious comorbidity
  • Ongoing immune respons after infection or vaccination \< 1 month
  • Cognitive without ability to understand and/or give an informed consent to participate in the study

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2022-03-14

View full record on ClinicalTrials.gov

All APOE4 clinical trials